Recommended public cash offer of Amgen Inc. to the shareholders of Nuevolution AB (publ)

Important Information

The information contained in this section of the website is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part in, into or from Australia, Canada, Hong Kong, Japan, New Zealand or South Africa, or any other jurisdiction where to do so may constitute a violation of applicable laws and regulations or require further filings or other measures in addition to those required under Swedish law.